In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998

Diagnostic Microbiology and Infectious Disease

Volumn 37, Issue 2, 2000, Pages 93-98

  Jones, Ronald N ^a   Jenkins, Stephen G ^b   Hoban, Daryl J ^c   Pfaller, Michael A ^a   Ramphal, Reuben ^d  

^a UNIVERSITY OF IOWA   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c HEALTH SCIENCES CENTRE   (Canada)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; OXACILLIN; PENICILLIN G;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CANADA; COAGULASE NEGATIVE STAPHYLOCOCCUS; HOSPITAL INFECTION; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; COAGULASE; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; NORTH AMERICA; OXACILLIN; PENICILLINS; PNEUMOCOCCAL INFECTIONS; SENTINEL SURVEILLANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0034116517     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(00)00125-5     Document Type: Article

References (12)

1. CDC. (1996). Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of a working group. MMWR Morb Mortal Wkly Rep 45(RR-1 suppl.):1-20.
2. CDC. (1999). Geographic variation in penicillin resistance in Streptococcus pneumoniae - selected sites, United States, 1997. MMWR Morb Mortal Wkly Rep 48, 656-661.
3. Doern G.V., Brueggemann A.B., Huynh H., Wingert E., Rhomberg P. Antimicrobial resistance with Streptococcus pneumoniae in the United States, 1997-1998. Emerg Infect Dis. 5:1999;757-765.
4. Edmond M.B., Wallace S.E., McClish D.K., Pfaller M.A., Jones R.N., Wenzel R.P. Nosocomial bloodstream infections in United States hospitals a three-year analysis . Clin Infect Dis. 29:1999;239-244.
5. National Committee for Clinical Laboratory Standards (1997). Methods For Dilution Antimicrobial Tests For Bacteria That Grow Aerobically: Approved Standard M7-A4. 4th ed. Wayne, PA: NCCLS.
6. National Committee for Clinical Laboratory Standards (1999). Performance Standards For Antimicrobial Susceptibility Testing; 9th Informational Supplement M100-S9. Wayne, PA: NCCLS.
7. Pfaller, M. A., Jones, R. N., Doern, G. V., Kugler, K., & the SENTRY participants study group (1998). Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 42, 1762-1770.
8. Richards, M. J., Edwards, J. R., Culver, D. H., & Gaynes, R. P. (1999). Nosocomial infections in pediatric intensive care units in the United States. Pediatrics 103, e39. http://www.pediatrics.org/cgi/content/full/103/4/e39.
9. Richards M.J., Edwards J.R., Culver D.H., Gaynes R.P. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med. 27:1999;887-892.
10. Thornsberry, C., Ogilvie, P. T., Holley Jr, & Sahm, D. F. Survey of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study (1999) Antimicrob Agents Chemother 43, 2612-2623.
11. Weinstein M.P., Towns M.L., Quartey S.M., Mirrett S., Reimer L.G., Parmigiani G., et al. The clinical significance of positive blood cultures in the 1990s a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults . Clin Infect Dis. 24:1997;584-602.
12. Zhanel G.G., Karlowsky J.A., Palatnick L., Vercaigne L., Low D.E., et al. Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae results of a Canadian national surveillance study . Antimicrob Agents Chemother. 43:1999;2504-2509.